The global acne medication market was valued at approximately USD 10.07 billion in 2024, fueled by the rising incidence of acne disorders and increasing adoption of retinoid-based treatments worldwide. The market is projected to expand at a CAGR of 4.20% from 2025 to 2034, reaching an estimated value of USD 15.20 billion by the end of the forecast period. https://www.expertmarketresearch.com/reports/acne-medication-market